Articles about AbSci

AI is boosting drug discovery and development — and sparking questions about proprietary data

The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business… Read More

Tech Moves: Seattle tech vet Liz Pearce joins climate startup; Absci names AI chief; and more

— Longtime tech executive Liz Pearce announced Monday that she is joining Seattle-based climate marketplace startup Ever.green as chief revenue… Read More

Biotech company Absci lays off 30 employees, about 15% of staff

Publicly traded biotech company Absci is laying off 30 employees, or approximately 15% of its workforce.

Tech Moves: Absci chief legal officer to depart; Cajal Neuroscience hires exec

— Sarah Korman, chief legal officer at Vancouver, Wash.-based biotech company Absci, will depart Sept. 15, according to a regulatory… Read More

Tech Moves: Hootsuite adds CMO; Flexe appoints COO; Absci names CFO

— Hootsuite appointed Elina Vilk as chief marketing officer. Vilk previously worked as CMO at Woocommerce, an open-source e-commerce plugin… Read More

How AI is changing the way scientists engineer drugs, biosensors, enzymes and more

Inside the headquarters of Outpace Bio in Seattle, senior scientist Bobby Langan shows a video of one of his favorite… Read More

Tech Moves: Ex-Philips CEO joins Absci board; AWS exec departs; and more

— Vancouver, Wash.-based AI drug design and development company Absci named Frans van Houten to its board of directors. A… Read More

Publicly traded biotech company Absci lays off employees, citing ‘macro-economic conditions’

Vancouver, Wash.-based drug design and development company Absci laid off employees Tuesday, a little more than a year after going… Read More

Tech Moves: Vimeo hires Seattle execs; Microsoft corporate VP retires; and more

— Vimeo appointed Lynn Girotto as chief marketing officer and Ashraf Alkarmi as chief product officer for the New York… Read More

Vancouver, Wash.-based biotech Absci opens new AI Research Lab in New York City

Absci, the Vancouver, Wash.-based biotech that provides drug and drug target discovery services to other companies, has opened a lab… Read More

Tech Moves: Athira Pharma adds Wave Life Sciences CMO Michael Panzara to board

—Michael Panzara, chief medical officer and head of therapeutics discovery and development for Wave Life Sciences, was appointed to Athira… Read More

Tech Moves: Adaptive CFO to resign; Meta comms exec departs; AI vet joins Absci board; new Zymeworks CEO

— Chad Cohen will step down as CFO of Adaptive Biotechnologies on Feb. 15. Prior to joining Adaptive in 2015,… Read More

Biotech company Absci, which recently went public, cuts ribbon on new HQ in Vancouver, Wash.

Absci cut the ribbon on its new headquarters in Vancouver, Wash., on Tuesday, barely three months after going public in… Read More

Tech Moves: Siblings at Seattle startup swap roles; Microsoft CVP departs to focus on DEI; and more

— IoT startup Mason announced that founder and current CEO Jim Xiao will be swapping roles with his sister and… Read More

How Sean McClain founded Absci at just 22 — and now leads a newly public biotech worth nearly $2B

Biotech CEOs tend to have advanced degrees and multiple academic credentials under their belt. But Sean McClain started Absci as… Read More

Absci shares spike 30% in IPO debut, valuing Washington state biotech company at nearly $2B

Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a… Read More

Absci’s IPO reflects booming biotech market and growing PNW life sciences industry

The upcoming public offering for Vancouver, Wash.-based biotech company Absci reflects a soaring IPO market and adds to the growing… Read More

Tech Moves: Edifecs names new CEO; Absci adds execs ahead of IPO; and more

— Biotech company Absci, which filed to go public last week, added Nikhil Goel as chief business officer and Sarah… Read More

Vancouver, Wash. biotech company Absci files to go public

Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to… Read More

Biotech startup AbSci raises $125M for ‘Protein Printing’ tech; total funding up to $230M

New funding: Vancouver, Wash.-based biotech company AbSci raised $125 million in a round led by Casdin Capital and Redmile Group. The… Read More

AbSci acquires AI startup Denovium to boost synthetic biology platform

AbSci has acquired Denovium, a 6-person bootstrapped startup out of San Diego that uses deep learning to analyze the function… Read More

Synthetic biology startup AbSci raises $65M to expand ‘Protein Printing’ tech

Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology platform. The company’s “Protein… Read More

Biomanufacturing company AbSci raises $12M to scale synthetic biology platform

Vancouver, Wash.,-based biotechnology company AbSci has raised a chunk of new money. The company announced Wednesday that it has just… Read More